The expression of insulin-like growth factor 2 messenger rna-binding protein 3 in langerhans cell histiocytosis and langerhans cell sarcoma

Konomi Yashige, Tatsuki R. Kataoka, Yosuke Yamada, Hirona Maeda, Marina Oji-Tsujimura, Tetsurou Yamamoto, Yusuke Takei, Koki Moriyoshi, Kazuo Ono, Yo Kaku, Tetsuya Tabata, Ichiro Murakami, Hirokazu Nakamine, Hironori Haga

Research output: Contribution to journalArticlepeer-review

Abstract

Langerhans cell neoplasms, which include Langerhans cell histiocytosis and Langerhans cell sarcoma, are tumors that originate from dendritic cells. Langerhans cell sarcoma is defined as a high-grade neoplasm with overtly malignant cytological features and the Langerhans cell-like phenotype, and generally has a poorer prognosis and more aggressive phenotype than Langerhans cell histiocytosis. Insulin-like growth factor 2 messenger RNA-binding protein 3 (IGF2BP3 or IMP3) is an oncofetal protein that is expressed in various cancer types; its expression is often associated with a poor prognosis and aggressive phenotype. Here, we used immunohistochemistry to evaluate IGF2BP3 expression in Langerhans cell neoplasms. IGF2BP3 expression was scored as negative (< 1%) or positive (≥ 1%) by immunohistochemistry. All 4 patients with Langerhans cell sarcoma (100%) and 6 of 22 pediatric (age < 18 years) patients with Langerhans cell histiocytosis (27.3%) had positive results for IGF2BP3; however, 16 of 22 pediatric patients with Langerhans cell histiocytosis (72.7%) and all 15 adult (age ≥ 18 years) patients with Langerhans cell histiocytosis (100%) had a negative result. Among patients with Langerhans cell histiocytosis, IGF2BP3 expression was independent of sex, location, prognosis, and BRAF V600E staining results. Taken together, these results indicate that IGF2BP3 expression may be a helpful marker for distinguishing Langerhans cell sarcoma from Langerhans cell histiocytosis in adult patients.

Original languageEnglish
Pages (from-to)27-31
Number of pages5
JournalTohoku Journal of Experimental Medicine
Volume255
Issue number1
DOIs
Publication statusPublished - Sep 2021

Keywords

  • IGF2BP3
  • Immunohistochemistry
  • Langerhans cell histiocytosis
  • Langerhans cell neoplasm
  • Langerhans cell sarcoma Tohoku J. Exp. Med., 2021 September, 255 (1), 27-31

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'The expression of insulin-like growth factor 2 messenger rna-binding protein 3 in langerhans cell histiocytosis and langerhans cell sarcoma'. Together they form a unique fingerprint.

Cite this